Science advisory committee on health products containing cannabis

As part of the development of the Cannabis Regulations in 2018, Health Canada committed to holding consultations regarding a potential approach for non-prescription health products containing cannabis. This consultation was launched on June 19, 2019 and closed on September 3, 2019.

The purpose of this consultation was to seek feedback from Canadians, as well as the cannabis and health products industries, regarding the kinds of products they would be interested in manufacturing, selling or purchasing, should a legal pathway to market for these products be established. As part of this consultation, the Department made a commitment to seek external scientific advice regarding the appropriate evidence standards for non-prescription health products containing cannabis.

Health Canada is establishing a new Science Advisory Committee for Health Products Containing Cannabis (referred to as “the Committee”) which will provide independent scientific and clinical advice to support the Department’s consideration of appropriate safety, efficacy, and quality standards for health products containing cannabis, including the conditions under which these products would be suitable to be used without practitioner oversight (e.g., dose and indication).

For more detailed information about the Committee, please consult the following:




Contact the committee by e-mail:

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: